NCI Resources

NCI CANCERLIT^® Search: BRCA1 Gene - October 2001 Is it good clinical judgment or selection bias? Tubal ligation and risk of ovarian cancer. Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Risk-reduction mastectomy: clinical issues and...
NCI CANCERLIT^® Search: BRCA1 Gene - September 2001 Table of ContentsPsychological impact of receiving a BRCA1/BRCA2 test result.Reading between the lines: direct-to-consumer advertising of genetic testing.Profiling of protein kinases in the neoplastic transformation of human ovarian surface...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - October 2001 Two inbred strains of mice with high and low mammary tumor potentials established from the same basal stock of Swiss albino (SHN and SLN): Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - September 2001 Table of ContentsPrognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.Polymorphisms in the DNA repair gene XRCC1 and breast cancer.Glutathione S-transferase M1, M3, P1, and T1...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - October 2001 Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Breast carcinoma in young patients. Breast carcinoma in young patients. Are older lymphoma and breast cancer patients undertreated? Pegylated...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - September 2001 Table of ContentsScleroderma in association with the use of docetaxel (taxotere) for breast cancer.Influence of adjuvant chemotherapy on skeletal muscle and fatigue in women with breast cancer.PM-3, a benzo-gamma-pyran derivative isolated...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - October 2001 Current status of radiation in the treatment of breast cancer. Contralateral breast cancer risk. Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy. A glance on quality...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - September 2001 Table of ContentsA cost-outcome analysis of adjuvant postmastectomy locoregional radiotherapy in high-risk postmenopausal breast cancer patients.The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - October 2001 Beyond HERS: some (not so) random thoughts on randomized clinical trials. Contralateral breast cancer risk. RAGs: A novel approach to computerized genetic risk assessment and decision support from pedigrees. Meeting highlights:...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - September 2001 Table of Contents[Breast cancer screening: a current topic]Update in general internal medicine.Too early to say that pregnancy has an antitumor effect on breast cancer.Waiting times from abnormal breast screen to diagnosis in 7 Canadian ...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - October 2001 [Stewart-Treves syndrome following mastectomy for breast cancer: a case report] Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective study. Breast conservation, mastectomy and...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - September 2001 Table of ContentsRadioguided sentinel lymph node biopsy in breast cancer surgery.Radioimmunoguided breast surgery using radiolabeled antibody NR-LU-10 FAB: a pilot study.Time trends in the results of breast conservation in 4694 women.[Minimally...
NCI CANCERLIT^® Search: BRCA1 Gene - April 2002 Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Re: familial multiple myeloma: a family study and review of the literature. Re: familial multiple myeloma: a family study...
NCI CANCERLIT^® Search: BRCA1 Gene - August 2002 Breast cancer risks: some clinically useful approaches. Prophylactic bilateral mastectomy: patterns of practice. The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients. Epigenetic factors...
NCI CANCERLIT^® Search: BRCA1 Gene - February 2002 Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. Estimating allele age. p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Fallopian tube cancer in a BRCA1...
NCI CANCERLIT^® Search: BRCA1 Gene - January 2002 [From gene to disease; from BRCA1 OR BRCA2 to breast cancer] Advances in the management of epithelial ovarian cancer. Terminal deoxynucleotidyltransferase is negatively regulated by direct interaction with proliferating cell nuclear antigen....
NCI CANCERLIT^® Search: BRCA1 Gene - July 2002 Risk-reduction mastectomy: clinical issues and research needs. Benign mental health consequences of screening for mutations of BRCA1/BRCA2. What do women really want to know? Motives for attending familial breast cancer clinics. Factors...
NCI CANCERLIT^® Search: BRCA1 Gene - June 2002 Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study. Structural determinants of BRCA1 translational regulation. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage. A change in the...
NCI CANCERLIT^® Search: BRCA1 Gene - March 2002 Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. Quality control in prophylactic mastectomy for women at high risk of breast cancer. Frequency of BRCA1...
NCI CANCERLIT^® Search: BRCA1 Gene - May 2002 Categorizing genetic tests to identify their ethical, legal, and social implications. Guidelines for evaluation of patients at risk for inherited breast and ovarian cancer: recommendations of the Department of Defense Familial Diagnostic...
NCI CANCERLIT^® Search: BRCA1 Gene - October 2002 Cancer. BRCA2 enters the fray. Cancer Incidence in BRCA1 mutation carriers. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. Inactivation of BRCA1 and BRCA2 in ovarian cancer. A rational approach to...
NCI CANCERLIT^® Search: BRCA1 Gene - September 2002 Codon-substitution models for detecting molecular adaptation at individual sites along specific lineages. Ovarian cancer in BRCA-positive women: vigilance is mandatory despite screening programs. Breast and ovarian cancer screening...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - April 2002 Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients. Clinical management of women with genomic BRCA1 and BRCA2 mutations. Expression of E2F-1 and E2F-4 is reduced in primary and metastatic breast carcinomas....
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - August 2002 A testing algorithm for determination of HER2 status in patients with breast cancer. Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele Communicating...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - February 2002 The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin Evaluating...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - January 2002 [From gene to disease; from BRCA1 or BRCA2 to breast cancer] Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial. Familial breast cancer in southern Taiwan. A single nucleotide...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - July 2002 BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers. Quantitative FISH analysis on interphase...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - June 2002 Nuclear chromatin characteristics of breast solid pattern ductal carcinoma in situ. Intracellular flow cytometric analysis of primary cultured breast tumor cells. Association of allelic losses at 3p25.1, 13q12, or 17p13.3 with poor ...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - March 2002 Uncertain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53. Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal BRCA1 and BRCA2...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - May 2002 The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40. Polymorphic CA repeats in the IGF-I gene and breast cancer. Molecular classification of primary breast tumors possessing distinct ...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - October 2002 [A study of human breast carcinoma xenografts in nude mice] Support groups for people carrying a BRCA mutation. Gene expression in inherited breast cancer. Analysis of gene expression involved in brain metastasis from breast cancer using...
NCI CANCERLIT^® Search: Breast Cancer, Hereditary - September 2002 Measures of familial aggregation as predictors of breast-cancer risk. Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years. A significant response to neoadjuvant...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - April 2002 A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles. HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer. Prognostic value of TP53...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - August 2002 Fulvestrant. [Evolvement of hormone therapy for breast cancer. Florence, March 14, 2001] Serologic concentrations of HER-2/neu in breast cancer patients with visceral metastases receiving trastuzumab therapy predict the clinical The...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - February 2002 Tamoxifen-induced female androgenetic alopecia in a patient with breast cancer. A randomized trial of four cycles of adjuvant AC (adriamycin + cyclophosphamide) +/- two cycles of EP (etoposide + cisplatin) in node Phase I dose-finding and...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - January 2002 Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - July 2002 Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. Tamoxifen and contralateral breast cancer: the other side. Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - June 2002 Standard medical treatment for early breast cancer. Utilization of sentinel lymph node mapping to determine pathologic outcomes for patients receiving neoadjuvant chemotherapy for locally A prospective trial of preoperative chemotherapy in...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - March 2002 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7. Screening mammography: setting the record straight. Bezwoda: evidence of fabrication in original...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - May 2002 New breast cancer drugs expand treatment options. DNA strand breaks and cell cycle perturbation in herceptin treated breast cancer cell lines. Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer....
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - October 2002 An evaluation of predictive factors involved in clinical or pathological response to primary chemotherapy in advanced breast cancer. Monotherapy with paclitaxel as third-line chemotherapy against anthracycline-pretreated and...
NCI CANCERLIT^® Search: Chemotherapy for Breast Cancer - September 2002 High-dose chemotherapy in advanced breast cancer. Fulvestrant (faslodex) for advanced breast cancer. A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer. Endometrial mixed Mullerian tumor with heterologous...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - April 2002 Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Wide-field radiation as adjunct to adjuvant chemotherapy in high-risk cases with early breast...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - August 2002 Radiotherapy for early breast cancer. Electron conformal radiotherapy using bolus and intensity modulation. Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. Preliminary results of a...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - February 2002 [Postoperative radiotherapy should be given also to women with breast cancer that are over 55 years] Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Treatment selection in...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - January 2002 Breast-conserving therapy for early-stage breast cancer. [Intraoperative electron radiotherapy (IOERT) in the QUART sequence: a phase I study] An intercomparison of IMRT delivery techniques: a case study for breast treatment. Breast...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - July 2002 Predictive factors for skin telangiectasia following post-mastectomy electron beam irradiation. Low heart risk after radiation therapy for breast cancer. Timing of radiotherapy in breast cancer conserving treatment. [Is there an indication...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - June 2002 Subcutaneous calcification following chest wall and breast irradiation: a late complication. Outcome with postmastectomy radiation with transverse rectus abdominis musculocutaneous flap breast reconstruction. Margin width as a...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - March 2002 Adjuvant irradiation for breast cancer. Adjuvant irradiation for breast cancer. Treatment plans need to be made with better anatomical information. The emerging role of brachytherapy in the management of patients with breast cancer....
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - May 2002 A study of high frequency ultrasound to assess cutaneous oedema in conservatively managed breast. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells. Chromosomal...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - October 2002 Impact of boost irradiation with surgically placed radiopaque clips on local control in breast-conserving therapy. Prognostic and predictive factors in the adjuvant treatment of breast cancer. Immunohistochemically detected p53 mutations...
NCI CANCERLIT^® Search: Radiotherapy for Breast Cancer - September 2002 Low heart risk after breast cancer radiation. Pathologic quiz case: a 68-year-old woman with bluish discoloration of the skin of the breast. [Is there an indication for additional local irradiation in conserving treatment of breast...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - April 2002 The evolving role of endocrine therapy for treatment and prevention of breast cancer. Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women. Effect of low dose tamoxifen on the insulin-like growth...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - August 2002 Biology and cost-benefit in mammography screening. Controversies in screening with mammography. Breast cancer risks: some clinically useful approaches. Breast health--introduction and overview. The controversy over estrogen replacement therapy:...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - February 2002 Cancer genetics in oncology practice. The pattern of breast cancer screening utilization and its consequences. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. American Cancer Society guidelines...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - January 2002 The risk of developing breast cancer within the next 5, 10, or 20 years of a woman's life. Detection of breast cancer. Mammography should be available. Pairing accountability with responsibility--the consequences of screening 'promotion'....
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - July 2002 Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Risk-reduction...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - June 2002 Use of alternatives to estrogen for treatment of menopause. The British Columbia Mammography Screening Program: evaluation of the first 15 months. Low-cost mass screening for breast cancer with mammography. The comparative value of...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - March 2002 New approaches to surgery for breast cancer. Physical activity in first-degree relatives of breast cancer patients. Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - May 2002 Two distinct groups of non-attenders in an organized mammography screening program. How to decrease the non-compliance in a clinical trial. Some radiologists want more money up front. Guidelines for evaluation of patients at risk for inherited...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - October 2002 Mammographic parenchymal patterns and risk of breast cancer at and after a prevalence screen in Singaporean women. Fat intake and breast cancer risk in an area where fat intake is low: a case-control study in Indonesia. Comparison of...
NCI CANCERLIT^® Search: Screening and Prevention of Breast Cancer - September 2002 The privatization of risk. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. [Primary and secondary breast cancer prevention. Knowledge, assessment and participation...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - April 2002 Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995. [Quantitative assessment of therapy related effects after breast conserving therapy with dynamic MRI of the breast]...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - August 2002 Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - February 2002 Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Treatment selection in ductal carcinoma in situ. 3D-MR mammography-guided breast conserving surgery after neoadjuvant ...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - January 2002 Re: Progression of idiopathic thoracolumbar scoliosis after breast reconstruction with a latissimus dorsi flap: a case report (Spine 2000; Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ....
NCI CANCERLIT^® Search: Surgery for Breast Cancer - July 2002 Risk-reduction mastectomy: clinical issues and research needs. 0.2% ropivacaine epidurally provides better analgesia and recovery than general anesthesia for patients undergoing oncological mastectomy. Limited incision with plastic bag...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - June 2002 A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - March 2002 New approaches to surgery for breast cancer. Sentinel nodes: clinical trial data needed. [Diagnosis and treatment of breast cancer with central and medial localization using video-assisted thoracoscopic parasternal Early results of an...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - May 2002 Experience with endoscopic axillary lymphadenectomy using needlescopic instruments in patients with breast cancer: a preliminary report. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - October 2002 Impact of boost irradiation with surgically placed radiopaque clips on local control in breast-conserving therapy. Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan. Results of...
NCI CANCERLIT^® Search: Surgery for Breast Cancer - September 2002 [Sentinel lymph nodes in breast cancer] Paravertebral somatic nerve blocks for breast surgery in a patient with hypertrophic obstructive cardiomyopathy. [Randomized prospective study of early removal of drainage in breast cancer surgery]...
NCI/PDQ^® Health professionals: Breast Cancer Prevention (PDQ®) TABLE OF CONTENTS OverviewFactors Associated With Increased Risk of Breast CancerHormone therapyIonizing radiationObesityAlcoholMajor inheritance susceptibilityFactors Associated With Decreased Risk of Breast CancerExercise Early...
NCI/PDQ^® Health professionals: Breast Cancer Screening (PDQ®) TABLE OF CONTENTS Summary of EvidenceScreening by MammographyStatement of benefitStatement of harmsScreening by Clinical Breast ExaminationStatement of benefitsStatement of harmsScreening by Breast Self-ExaminationStatement of benefitStatement of...
NCI/PDQ^® Health professionals: Breast Cancer Treatment (PDQ®) TABLE OF CONTENTS General Information About Breast CancerIncidence and MortalityGenetic Characteristics and Risk FactorsScreeningPatient EvaluationPrognostic and Predictive FactorsContralateral DiseaseHormone Replacement TherapyBreast...
NCI/PDQ^® Health professionals: Breast Cancer Treatment and Pregnancy (PDQ®) TABLE OF CONTENTS General Information About Breast Cancer Treatment and PregnancyStage Information for Breast Cancer Treatment and PregnancyOther Considerations for Pregnancy and Breast CancerLactationFetal Consequences of Maternal Breast...
NCI/PDQ^® Health professionals: Genetics of Breast and Ovarian Cancer (PDQ®) TABLE OF CONTENTS IntroductionGeneral InformationFamily History as a Risk Factor for Breast CancerFamily History as a Risk Factor for Ovarian CancerAutosomal Dominant Inheritance of Breast/Ovarian Cancer PredispositionDifficulties in Identifying a...
NCI/PDQ^® Health professionals: Male Breast Cancer Treatment (PDQ®) TABLE OF CONTENTS General Information About Male Breast CancerIncidence and MortalityTreatment Options for Male Breast CancerInitial Surgical ManagementAdjuvant TherapyLocally Recurrent DiseaseDistant MetastasesChanges to This Summary...
NCI/PDQ^® Pacientes: Cáncer del seno (mama) masculino: Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre el cáncer de mama masculinoEstadios del cáncer de mama masculinoCáncer de mama masculino inflamatorioCáncer de mama masculino recidivante Aspectos generales de las opciones de...
NCI/PDQ^® Pacientes: Cáncer del seno (mama): Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre el cáncer del seno (mama)Estadios del cáncer de seno (mama)Cáncer de mama inflamatorioCáncer de mama recidivanteAspectos generales de las opciones de tratamientoOpciones de...
NCI/PDQ^® Pacientes: Tratamiento del cáncer de seno (mama) en el embarazo (PDQ®) TABLE OF CONTENTS Información general sobre el cáncer de mama en el embarazo Estadios del cáncer de mamaCáncer de mama inflamatorioCáncer de mama recidivanteAspectos generales de las opciones de tratamiento Opciones de...
NCI/PDQ^® Patients: Breast Cancer Screening (PDQ®) TABLE OF CONTENTS What is screening?General Information About Breast CancerBreast Cancer ScreeningRisks of Breast Cancer ScreeningChanges to This Summary (08/18/2011)Questions or Comments About This SummaryGet More Information From NCIAbout PDQ®...
NCI/PDQ^® Patients: Breast Cancer Treatment (PDQ®) TABLE OF CONTENTS General Information About Breast CancerStages of Breast CancerInflammatory Breast CancerRecurrent Breast CancerTreatment Option OverviewTreatment Options by StageDuctal Carcinoma In Situ (DCIS)Lobular Carcinoma In Situ (LCIS)Stage...
NCI/PDQ^® Patients: Breast Cancer Treatment and Pregnancy (PDQ®) TABLE OF CONTENTS General Information about Breast Cancer and PregnancyStages of Breast CancerInflammatory Breast CancerRecurrent Breast CancerTreatment Option OverviewTreatment Options by StageEarly Stage Breast Cancer (Stage I and Stage II)Late...
NCI/PDQ^® Patients: Male Breast Cancer Treatment (PDQ®) TABLE OF CONTENTS General Information about Male Breast CancerStages of Male Breast CancerInflammatory Male Breast CancerRecurrent Male Breast CancerTreatment Option OverviewTreatment Options for Male Breast Cancer Initial SurgeryAdjuvant...
NCI/PDQ^® Patients: Prevention of Breast Cancer TABLE OF CONTENTS Overview of PreventionPreventionPurposes of this summaryBreast Cancer PreventionSignificance of breast cancerBreast cancer preventionChanges to This Summary (02/20/2007)Questions or Comments About This SummaryTo Learn MoreAbout...
NCI/PDQ^® Physician Statement: Planificación del cuidado de transición TABLE OF CONTENTS Descripción Definición (es) Componentes de los exàmenes de detección específicos a la evaluación biopsicosocial Evaluación biopsicosocial extensa Intervenciones u opciones biopsicosociales...
NCI/PDQ^® Profesionales De Salud: Cáncer del seno (mama) masculino: Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre el cáncer del seno (mama) masculinoIncidencia y mortalidadOpciones de tratamiento para el cáncer de mama masculinoManejo quirórgico inicialTerapia adyuvanteEnfermedad recidivante...
NCI/PDQ^® Profesionales De Salud: Cáncer del seno (mama): Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre el cáncer de mamaIncidencia y mortalidadCaracterísticas genéticas y factores de riesgoExámenes de detecciónEvaluación de la pacienteFactores pronósticos y valor...
NCI/PDQ^® Profesionales De Salud: Tratamiento del Cáncer de seno (mama) en el embarazo (PDQ®) TABLE OF CONTENTS Información general sobre el tratamiento del cáncer de mama en el embarazoInformación sobre los estadios para el tratamiento del cáncer de mama durante el embarazoOtras consideraciones relativas al embarazo y el...
Non-Hodgkin's Lymphoma Introduction The non-Hodgkin's lymphomas comprise a diverse collection of lymphoreticular neoplasms usually but not necessarily arising in nodal tissue. They account for about 4% of newly diagnosed adult cancers and are among the leading causes of...